Search clinical trials for: Niraparib Tablet

Total 7517 results

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects

Influenza

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects

Asthma

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation (mCRPC)

Metastatic Castration Resistant Prostate Cancer
National Cheng-Kung University Hospital
Chang Gung Memorial Hospital

Completed

Stochastic Resonance Applied to Amblyopia Training and the Plasticity of Brain

Amblyopia | Amblyopia, Anisometropic
University of California, San Francisco

Completed

Computer-Facilitated 5A's for Smoking Cessation in Primary Care

Smoking Cessation | Nicotine Addiction

United States
Beijing Tide Pharmaceutical Co., Ltd

Not yet recruiting

A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

Refractory Chronic Cough
Beijing Tide Pharmaceutical Co., Ltd

Recruiting

A Phase I/II Clinical Study in Patients With Advanced Solid Tumor.

Patients With Advanced Solid Tumors

China
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

Study of TFX06 in Women With Advanced Breast Cancer.

Metastatic Breast Cancer | ER+, HER2- Advanced Breast Cancer

China
Gustave Roussy, Cancer Campus, Grand Paris
Bayer

Recruiting

Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma (REGO-EWING)

Bone Cancer

France
Centre Hospitalier Eure-Seine

Not yet recruiting

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk (TEVEDOM)

Thromboembolic Disease
Suzhou Genhouse Bio Co., Ltd.

Recruiting

Dose Finding Study of GH35 in Patients With Advanced Solid Tumors

AdvAdvanced Solid Tumors | Kirsten Rat Sarcoma

China
Shandong Suncadia Medicine Co., Ltd.

Active, not recruiting

A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers

Type II Diabetes

China
Gannex Pharma Co., Ltd.
Hunan Provincial People's Hospital

Completed

Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers

Healthy | NAFLD | Hyperlipidemia

China
Medical University of Graz
Joanneum Research Forschungsgesellschaft mbH; Sozialverein Deutschlandsberg... and other collaborators

Unknown

Playful Multimodal Intervention, Monitoring and Decision Support for Activation of People With Alzheimer's Dementia (M-AAL)

Alzheimer Disease

Austria
Hubei Biological Medicine Industrial Technology...

Unknown

Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors

Advanced Solid Tumors | HRD | BRCA Mutation

China
Azienda Ospedaliero, Ferrarotto Alessi
Abbott Medical Devices

Unknown

Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing Mitraclip Transcatheter Repair (HERMES)

Heart Failure | Mitral Regurgitation

Italy
University College, London
L.V. Prasad Eye Institute

Unknown

CREATE - Children Reading With Electronic Assistance To Educate (CREATE)

Child | Vision, Low | Adolescent Development

United Kingdom, India
NYU Langone Health

Completed

Evaluation of Salt Sensitivity in Young Adults

Healthy Volunteers

United States
Herlev Hospital
Tachista

Completed

Food'to'Go - a Feasibility Study of Post-discharge Meals for Older Patients by the Use of ICT-technology

Malnutrition

Denmark
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Active, not recruiting

Deferiprone to Delay Dementia (The 3D Study)

Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Mild Alzheimer's Disease

Australia
Korea University Anam Hospital
Takeda; Korean Cancer Study Group

Not yet recruiting

Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency

Efficacy
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers (PALB2-PARPi-01)

Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
Tianjin Huanhu Hospital

Recruiting

Niraparib Combined With Radiotherapy in rGBM

Recurrent Glioblastoma

China
Royal Marsden NHS Foundation Trust

Recruiting

Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR (MONITOR-UK)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United Kingdom
Mario Negri Institute for Pharmacological Research
North Eastern German Society of Gynaecological Oncology

Active, not recruiting

Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer) (Newton)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Italy, Germany
Dana-Farber Cancer Institute
Tesaro, Inc.

Active, not recruiting

Niraparib in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Centre Hospitalier Universitaire Vaudois
University College, London; Great Ormond Street Hospital for Children NHS Foundation...

Not yet recruiting

Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale

Heart Failure

Switzerland, United Kingdom
Pharma Plant
Novagenix Bioanalytical Drug R&D Center

Unknown

Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions

Bioequivalence

Turkey
GlaxoSmithKline

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Neoplasms

United States, Canada
Centre Leon Berard
GlaxoSmithKline

Recruiting

Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer (PARPi-PANC)

Metastatic Pancreatic Cancer

France
Northwell Health
Tesaro, Inc.

Recruiting

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

Endometrial Cancer | Endometrial Carcinoma | Uterine Serous Carcinoma | Cancer of the Endometrium | Papillary Serous Endometrial Carcinoma

United States
Shadia Jalal, MD
GlaxoSmithKline; Indiana University School of Medicine

Active, not recruiting

A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma

Adenocarcinoma | Gastric Cancer | Esophageal Cancer

United States
Ospedale Policlinico San Martino
CRO "Centro Clinical Trials" IRCCS Ospedale Policlinico San Martino; Laboratory...

Withdrawn

Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy (Bohème)

Metastatic Colorectal Cancer
GlaxoSmithKline

Active, not recruiting

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease (ZEST)

Neoplasms, Breast

United States, Argentina, France, Netherlands, Finland, Spain, Israel, Poland, Romania, Mexico, Canada, Belgium, Germany, Hungary, Portugal, United Kingdom, Ireland, Australia, Italy, Brazil, Japan, Austria, Russian Federation, South... and more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zai Lab (Shanghai) Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma. (CC-ANNIE)

Platinum-resistant Recurrent Clear Cell Ovarian Cancer

China
Assistance Publique - Hôpitaux de Paris
Groupe Hospitalier Paris Saint Joseph; French National Network of Clinical...

Completed

Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections (TEMO-CARB)

Urinary Tract Infections

France
Sunnybrook Health Sciences Centre
GlaxoSmithKline

Recruiting

Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer

Ovarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian Cancer

Canada
Zhejiang Cancer Hospital
Sun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaborators

Not yet recruiting

Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency

Triple Negative Breast Cancer | Homologous Recombination Deficiency
Ling-Ying Wu

Not yet recruiting

Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (RENI-1)

Epithelial Ovarian Cancer
Tongji Hospital
Sun Yat-sen University; Qilu Hospital of Shandong University; Hubei Cancer Hospital and other collaborators

Recruiting

Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Ovarian Cancer

China
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients

MDD

Bangladesh
Genentech, Inc.

Completed

Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810

Healthy Volunteer

United Kingdom
Genentech, Inc.

Completed

A Study to Evaluate the Effect of Particle Size, Formulation and Food on the Pharmacokinetics of GDC-0032 in Healthy Volunteers

Healthy Volunteer

United States
University Hospital, Clermont-Ferrand
Dr Gisèle PICKERING (MCU-PH)(Clinical Pharmacology center, Inserm 501); Dr...

Completed

Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg. (BioChronoMag)

Healthy Volunteers

France
KBP Biosciences
Worldwide Clinical Trials

Completed

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease (BLOCKCKD)

Hypertension | Chronic Kidney Diseases

United States
Center Laboratories, Inc.

Completed

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

T2DM With Inadequate Glycemic Control

Taiwan, United States
Joslin Diabetes Center
Massachusetts Institute of Technology

Completed

Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration

Type II Diabetes

United States
Shanghai Haini Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers

Bioequivalence

China
ViiV Healthcare

Completed

A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. (P1A114919)

Multiple Sclerosis, Relapsing-Remitting

Australia

Search clinical trials for: Niraparib Tablet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations